Recent advances on dual inhibitors targeting HIV reverse transcriptase associated polymerase and ribonuclease H

Reverse transcriptase (RT) plays an indispensable role in the replication of human immunodeficiency virus (HIV) through its associated polymerase and ribonuclease H (RNase H) activities during the viral RNA genome transformation into proviral DNA. Due to the fact that HIV is a highly mutagenic virus and easily resistant to single-target RT inhibitors, dual inhibitors targeting HIV RT associated polymerase and RNase H have been developed. These dual inhibitors have the advantages of increasing efficacy, reducing drug resistance, drug-drug interactions, and cytotoxicity, as well as improving patient compliance. In this review, we summarize recent advances in polymerase/RNase H dual inhibitors focusing on drug design strategies, and structure-activity relationships and share new insights into developing anti-HIV drugs.

[Diagnostic value of MRI in non-traumatic osteonecrosis of femoral head at early stage]

To determine whether magnetic resonance imaging (MRI) can demonstrate the early stage changes of avascular necrosis of the femoral head that are not detectable radiographically. Clinical examinations, radiography and MRI were performed in twenty-six patients (thirty hips) at high risk. On the basis of the pathological findings of core biopsies, the results demonstrate that MRI had an accuracy of 96.7% in diagnosing pre-radiologic stage necrosis of the femoral head in this series.